Chemically modified non-antimicrobial tetracycline derivatives and other low-molecular-weight synthetic matrix metalloproteinase (MMP) inhibitors inhibited keratinocyte migration. Since 72-kDa gelatinase-A (MMP-2) was the major gelatinase in our culture conditions, the results suggest that this MMP may be important in the regulation of keratinocyte mobility. On the other hand, we measured only gelatinase activities (MMP-2 and -9) present in culture medium, and therefore the results do not reveal how the inhibitors affect other MMPs as well as MMP levels close to the cell membranes. Overall, CMTs were found to be efficient in the inhibition of keratinocyte migration.
Aimes RT, Quigley JP (1995). Matrix metalloproteinase-2 is an interstitial collagenase. J Biol Chem270:5872-5876.
2.
Birkedal-Hansen H. (1995). Proteolytic remodeling of the extracellular matrix . Curr Opin Cell Biol7:728-735.
3.
Brown PD, Giavazzi R. (1995). Matrix metalloproteinase inhibition: a review of anti-tumor activity. Ann Oncol6:967-974.
4.
Chambers AF, Matrisian LM (197). Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst89:1260-1270.
5.
Golub LM, Suomalainen K., Sorsa T. (1992). Host modulation by tetracyclines and their chemically-modified non-antimicrobial derivatives. Curr Opin Dent2:80-90.
6.
Hanemaaijer R., Sorsa T., Konttinen YT, Ding Y., Sutinen M., Visser H., et al. (1997). Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-a and doxycycline. J Biol Chem272:31504-31509.
7.
Knauper V., Lopez-Otín C., Smith B., Knight G., Murphy G. (1996). Biochemical characterization of collagenase-3 . J Biol Chem271:1544-1550.
8.
Makela M., Salo T., Larjava H. (1999). MMP-9 from TNFastimulated keratinocytes binds to cell membranes and type I collagen: a cause to extended matrix degradation . J Cell Physiol (submitted).
9.
Nip LH, Uitto V.-J, Golub LM (1993). Inhibition of epithelial cell matrix metalloproteinases by tetracyclines. J Periodont Res28:379-385.
10.
Sorsa T., Ding Y., Salo T., Lauhio A., Teronen 0, Ingman T., et al. (1994). Effects of tetracyclines on neutrophil, gingival and salivary collagenases. Ann NYAcad Sci732:112-131.
11.
Sorsa T., Salo T., Koivunen E., Tyynela J., Konttinen YT, Bergmann U., et al. (1997). Activation of type IV pro-collagenases by human tumor-associated trypsin-2. J Biol Chem272:21067-21074.
12.
Sorsa T., Ramamurthy NS, Vemillo A., Zhang X., Konttinen YT, Rifkin BR, et al. (1998). Functional sites of chemically-modified tetracyclines: inhibition of the oxidative activation of human neutrophil and chicken osteoclast promatrix metalloproteinases. J Rheumatol25: 975-982.
13.
Uitto V.-J, Firth JD, Nip L., Golub LM (1994). Doxycycline and chemically-modified tetracyclines inhibt gelatinase A (MMP-2) gene expression in human skin keratinocytes. Ann NY Acad Sci732:140-151.
